Geneos Wealth Management Inc. Abb Vie Inc. Transaction History

Geneos Wealth Management Inc.

$2.6 Billion
Q3 2024

A detailed history of Geneos Wealth Management Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Geneos Wealth Management Inc. holds 32,215 shares of ABBV stock, worth $5.8 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares

32,215

Previous 29,431 9.46%

Holding current value

$5.8 Million

Previous $5.05 Million 26.01%

% of portfolio

0.24%

Previous 0.23%

35 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$163.84 - $199.33 $456,130 - $554,934	2,784 Added 9.46%	32,215 $6.36 Million
Q2 2024 Jul 23, 2024	SELL	$154.79 - $180.76 $44,115 - $51,516	-285 Reduced 0.96%	29,431 $5.05 Million
Q1 2024 May 03, 2024	SELL	$159.82 - $182.1 $134,728 - $153,510	-843 Reduced 2.76%	29,716 $5.41 Million
Q4 2023 Jan 26, 2024	SELL	$137.6 - $154.97 $601,174 - $677,063	-4,369 Reduced 12.51%	30,559 $4.74 Million
Q3 2023 Oct 11, 2023	SELL	$133.59 - $154.65 $209,068 - $242,027	-1,565 Reduced 4.29%	34,928 $5.21 Million
Q2 2023 Aug 08, 2023	BUY	$132.51 - $164.9 $329,419 - $409,941	2,486 Added 7.31%	36,493 $4.92 Million
Q1 2023 Apr 25, 2023	SELL	$144.61 - $166.54 $666,941 - $768,082	-4,612 Reduced 11.94%	34,007 $5.42 Million
Q4 2022 Jan 30, 2023	SELL	$138.31 - $165.87 $380,352 - $456,142	-2,750 Reduced 6.65%	38,619 $6.25 Million
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $2.22 Million - $2.55 Million	-16,537 Reduced 28.56%	41,369 $5.55 Million
Q2 2022 Jul 22, 2022	SELL	$137.62 - $174.96 $75,415 - $95,878	-548 Reduced 0.94%	57,906 $8.87 Million
Q1 2022 May 16, 2022	SELL	$131.98 - $163.75 $557,219 - $691,352	-4,222 Reduced 6.74%	58,454 $9.48 Million
Q4 2021 Feb 09, 2022	SELL	$107.43 - $135.93 $988,356 - $1.25 Million	-9,200 Reduced 12.8%	62,676 $8.49 Million
Q3 2021 Nov 09, 2021	BUY	$106.4 - $120.78 $68,521 - $77,782	644 Added 0.9%	71,876 $7.88 Million
Q2 2021 Jul 08, 2021	SELL	$105.21 - $117.21 $1.28 Million - $1.43 Million	-12,192 Reduced 14.61%	71,232 $8.2 Million
Q1 2021 Jun 17, 2021	BUY	$102.3 - $112.62 $165,009 - $181,656	1,613 Added 1.97%	83,424 $9.3 Million
Q4 2020 May 19, 2021	BUY	$80.49 - $108.67 $2.06 Million - $2.79 Million	25,643 Added 45.65%	81,811 $7.65 Million
Q3 2020 Sep 07, 2021	SELL	$85.91 - $100.83 $372,849 - $437,602	-4,340 Reduced 7.17%	56,168 $4.84 Million
Q2 2020 Sep 07, 2021	BUY	$73.37 - $98.18 $325,762 - $435,919	4,440 Added 7.92%	60,508 $5.82 Million
Q1 2020 Sep 07, 2021	BUY	$64.5 - $97.79 $282,058 - $427,635	4,373 Added 8.46%	56,068 $4.07 Million
Q4 2019 Sep 07, 2021	BUY	$72.13 - $90.25 $53,881 - $67,416	747 Added 1.47%	51,695 $4.61 Million
Q3 2019 Sep 07, 2021	BUY	$62.98 - $75.72 $10,643 - $12,796	169 Added 0.33%	50,948 $3.81 Million
Q2 2019 Sep 07, 2021	BUY	$65.7 - $83.98 $152,029 - $194,329	2,314 Added 4.77%	50,779 $3.69 Million
Q1 2019 Sep 07, 2021	SELL	$77.14 - $90.79 $33,324 - $39,221	-432 Reduced 0.88%	48,465 $3.91 Million
Q4 2018 Sep 07, 2021	BUY	$77.85 - $96.01 $90,695 - $111,851	1,165 Added 2.44%	48,897 $4.46 Million
Q3 2018 Sep 07, 2021	BUY	$88.91 - $98.84 $1.05 Million - $1.17 Million	11,844 Added 33.0%	47,732 $4.51 Million
Q2 2018 Sep 07, 2021	SELL	$89.78 - $106.23 $365,494 - $432,462	-4,071 Reduced 10.19%	35,888 $3.33 Million
Q1 2018 Sep 07, 2021	SELL	$92.01 - $123.21 $12,329 - $16,510	-134 Reduced 0.33%	39,959 $3.78 Million
Q4 2017 Sep 07, 2021	SELL	$89.56 - $98.21 $138,370 - $151,734	-1,545 Reduced 3.71%	40,093 $3.88 Million
Q3 2017 Sep 07, 2021	SELL	$69.85 - $89.22 $300,005 - $383,199	-4,295 Reduced 9.35%	41,638 $3.7 Million
Q2 2017 Sep 07, 2021	SELL	N/A	-1,163 Reduced 2.47%	45,933 $3.33 Million
Q1 2017 Sep 07, 2021	BUY	N/A	720 Added 1.55%	47,096 $3.07 Million
Q4 2016 Sep 07, 2021	SELL	N/A	-5,607 Reduced 10.79%	46,376 $2.9 Million
Q3 2016 Sep 07, 2021	BUY	N/A	7,152 Added 15.95%	51,983 $3.28 Million
Q2 2016 Sep 07, 2021	SELL	N/A	-1,178 Reduced 2.56%	44,831 $2.81 Million
Q1 2016 Sep 07, 2021	BUY	N/A	46,009	46,009 $2.64 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Geneos Wealth Management Inc. with notifications on news.

Account

Geneos Wealth Management Inc. Abb Vie Inc. Transaction History